• Lars Abrahmsen, Ph.D., Chief Scientific Officer, Affibody AB
• Eric Althoff, Ph.D., Head of Chemistry, Arzeda
• Katja Arndt, Ph.D., Principle Investigator, University of Freiburg
• Patrick Baeuerle, Ph.D., Chief Scientific Officer and SVP, R&D, Micromet AG
• H Kaspar Binz, Ph.D.,Vice President of Technology & Co-Founder, Molecular Partners AG
• Stuart Bussell , Ph.D., Director, Process Sciences, Ambrx, Inc.
• Jeffrey Cleland, Ph.D., CEO, Versartis
• William Dall'Acqua, Ph.D., Director, R&D, Medimmune
• Jonathan Davis, Ph.D., Principal Scientist, Protein Design, Adnexus, A Bristol-Myers Squibb R&D Co.
• Helen Dooley, Ph.D., Senior Research Scientist, Wyeth Research
• Mick Foley, Ph.D., Chief Scientific Officer, AdAlta
• Germaine Fuh, Ph.D., Scientist, Genentech, Inc.
• Eric Furfine, Ph.D., Senior Vice President, Adnexus, A Bristol-Myers Squibb R&D Co.
• Pete Gagnon, MS., Chief Scientific Officer, Validated Biosystems
• Gurkan Guntas , Ph.D., Postdoctoral Research Associate, University of North Carolina at Chapel H
• Bruce Hamilton, Ph.D., Principal Scientist, Domantis Limited
• Tracy Handel, Ph.D., Professor, University of California, San Diego
• Gottfried Himmler, Ph.D., CEO, f-star Biotechnology
• Josefin-Beate (Josi), Holz, M.D., Chief Medical Officer, Ablynx NV
• Kristian Jensen, Ph.D., Chief Operating Officer, Pieris AG
• Syd Johnson, Ph.D., Vice President, MacroGenics Incorporated
• Robert Charles Ladner, Ph.D., Chief Technology Officer, Dyax Corp.
• Edward Lanphier, President and CEO, Sangamo BioSciences, Inc.
• Ann MacLaren, Ph.D., Scientist II, Biogen Idec, Inc.
• Edwin Madison, Ph.D., Chief Scientific Officer, Catalyst Biosciences
• Brian Miller, Ph.D., Senior Scientist, Biogen Idec, Inc.
• Kendall Mohler, Ph.D., Senior Vice President, Trubion Pharmaceuticals
• Karyn O'Neil, Ph.D., Chief Scientific Officer, Centyrex, J&J Internal Ventures
• Paul Parren, Ph.D., Senior Vice President, Genmab
• Ira Pastan, M.D., Chief, National Cancer Institute NIH
• Marjorie Shapiro, Ph.D., Chief, CDER/FDA
• Arne Skerra, Ph.D., Professor, Technical University of Munich
• Willem 'Pim' Stemmer, Ph.D., Founder & CEO, Amunix, Inc.
• Arnd Steuernagel, Ph..D., Chief Scientific Officer, Scil Proteins GmBH
• David Urech , Ph.D., Head of R&D, ESBATech
• Zhulun Wang, Ph.D., Scientific Director, Amgen, Inc.
• Paul Watt, Ph.D., Vice President, Research, Phylogica Ltd.
• Jeffrey Way, Ph.D., Senior Staff Scientist, Wyss Institute for Biologically Inspired
• David Wilson, Ph.D., Vice President of R&D USA, Arana Therapeutics, Inc.
• Michael Wittekind, Ph.D., Executive Director, Protein Science, Amgen Inc
• Gary Woodnutt, Ph.D., Vice President of Biology, CovX Research LLC
• Chengbin Wu, Ph.D., Associate Research Fellow, Abbott Bioresearch Center
• Paul Yazaki, Ph.D., Research Professor, Beckman Research Institute

Scientific Advisory Board

• Jonathan Davis, Ph.D., Principal Scientist, Protein Design, Adnexus, A Bristol-Myers Squibb Company
• David S. Wilson, Ph.D., Vice President of R&D, Arana Therapeutics
• Willem 'Pim' Stemmer, Ph.D., CEO, Amunix, Inc.
• Dasa Lipovsek, Ph.D., Director of Protein Engineering, Codon Devices, Inc
• Dragan Grabulovski, Ph.D., Chief Scientific Officer, Covagen AG
• Paul Watt, Ph.D., Vice President, Research, Phylogica Ltd. Australia
• Horacio G. Nastri, Ph.D., Head of Phage Technology, EMD Serono Research Center, Inc.
• Russ Frost, R&D Manager, Process Chromatography Division, Life Science Group, Bio-Rad Laboratories, Inc.
• Bruce Dawson, Vice President, BAC bv, The Bio Affinity Company